|

Immune Globulin Infusion (Human), 10% Solution Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GAMMAGARD LIQUID

Pipeline

Phase 2: 1

Top Sponsors

  • Fred Hutchinson Cancer Center1

Indications

  • Hematologic Malignancies1
  • Cancer1

Duarte, California1 trial

IVIG for Infection Prevention After CAR-T-Cell Therapy

City of Hope Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.